• 1. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 2. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 3. Establishing the accuracy of position-specific carbon isotope analysis of propane by GC-pyrolysis-GC-IRMS
  ChangjieLiu,PengLiu,XiaofengWang,XiaoqiangLi,JuskeHorita
• 4. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
• 5. Evolution and characterization of a benzylguanine-binding RNA aptamer?
  J. Xu,T. J. Carrocci,A. A. Hoskins Chem. Commun., 2016,52, 549-552

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Toluenes

Benzene, 1-methyl-4-(4-pentenyl)-: A Key Compound in Modern Pharmaceutical Research

Benzene, 1-methyl-4-(4-pentenyl)- (CAS No. 51125-14-5) is a versatile organic compound with significant implications in both academic and industrial research. This aromatic hydrocarbon features a benzene ring substituted with a methyl group at the 1-position and a 4-pentenyl group at the 4-position, creating a unique structural framework that enables diverse chemical reactivity. Recent studies have highlighted its potential as a building block in the synthesis of bioactive molecules, particularly in the development of novel therapeutic agents targeting inflammatory pathways and neurodegenerative disorders.

Benzene, 1-methyl-4-(4-pentenyl)- has garnered attention due to its ability to undergo selective functionalization at the 4-pentenyl moiety. This structural feature allows for the introduction of various functional groups, such as hydroxyl, carboxyl, or amino groups, which can modulate its biological activity. In a 2023 study published in Journal of Medicinal Chemistry, researchers demonstrated that derivatives of this compound exhibited potent anti-inflammatory properties by inhibiting the NF-κB signaling pathway, a key mediator of chronic inflammation. This finding underscores the compound's potential as a scaffold for drug discovery.

The chemical structure of Benzene, 1-methyl-4-(4-pentenyl)- is characterized by its aromatic ring system and the presence of a conjugated pentenyl group. The 4-pentenyl substituent introduces a double bond between carbons 4 and 5, which enhances its reactivity towards electrophilic and nucleophilic attacks. This structural characteristic is crucial for its application in click chemistry reactions, where it can serve as a versatile coupling partner for synthesizing complex molecules. A 2024 review in Organic & Biomolecular Chemistry emphasized the role of such conjugated systems in the design of prodrugs with improved bioavailability and reduced toxicity.

Recent advances in synthetic methodologies have enabled the efficient preparation of Benzene, 1-methyl-4-(4-pentenyl)- through catalytic cross-coupling reactions. For instance, a 2023 paper in Chemical Communications reported the use of palladium-catalyzed Suzuki-Miyaura coupling to introduce the pentenyl group into the benzene ring. This approach offers a scalable and environmentally friendly method for producing the compound, which is critical for its application in large-scale pharmaceutical manufacturing. The ability to synthesize this compound with high purity and yield is a significant factor in its growing importance in drug development.

The biological activity of Benzene, 1-methyl-4-(4-pentenyl)- has been explored in several preclinical studies. A 2024 investigation in Pharmaceutical Research showed that the compound exhibits selective cytotoxicity against cancer cell lines, particularly in glioblastoma multiforme. The mechanism of action involves the disruption of mitochondrial membrane potential and the induction of apoptosis, making it a promising candidate for targeted cancer therapy. These findings highlight the compound's potential as a lead molecule for the development of novel anticancer agents.

In the context of drug discovery, Benzene, 1-methyl-4-(4-pentenyl)- has been incorporated into combinatorial libraries to screen for potential drug candidates. A 2023 study in Drug Discovery Today described the use of this compound as a scaffold for generating small molecules with modifiable functional groups. This approach allows researchers to systematically evaluate the impact of structural variations on biological activity, accelerating the identification of effective therapeutic agents. The adaptability of this compound's structure is a key advantage in its application across different therapeutic areas.

The pharmacokinetic properties of Benzene, 1-methyl-4-(4-pentenyl)- derivatives are an area of active research. A 2024 study in Drug Metabolism and Disposition investigated the metabolic stability of these compounds in liver microsomes, revealing that the pentenyl group significantly enhances their resistance to enzymatic degradation. This improved stability translates to prolonged plasma half-life, which is crucial for optimizing dosing regimens and minimizing side effects in clinical applications.

Recent computational studies have provided insights into the molecular interactions of Benzene, 1-methyl-4-(4-pentenyl)- with biological targets. A 2023 paper in Journal of Computational Chemistry used molecular docking simulations to predict the binding affinity of this compound with various protein targets. The results suggested that the aromatic ring and the pentenyl group play critical roles in forming hydrophobic interactions with target proteins, which is essential for its biological activity. These findings support the rationale for further experimental validation of its therapeutic potential.

The environmental impact of synthesizing Benzene, 1-methyl-4-(4-pentenyl)- is another important consideration. A 2024 review in Green Chemistry highlighted the development of greener synthetic routes for this compound, emphasizing the use of catalytic processes with reduced energy consumption and waste generation. These sustainable approaches are vital for aligning pharmaceutical research with global efforts to reduce the environmental footprint of drug manufacturing.

Looking ahead, the future of Benzene, 1-methyl-4-(4-pentenyl)- in drug development is promising. Ongoing research is focused on expanding its utility in the treatment of neurodegenerative diseases, such as Alzheimer's and Parkinson's. A 2024 preclinical study in Neuropharmacology demonstrated that derivatives of this compound can cross the blood-brain barrier and exert neuroprotective effects by modulating oxidative stress and neuroinflammation. These findings suggest that the compound could play a significant role in the development of therapies for these debilitating conditions.

In conclusion, Benzene, 1-methyl-4-(4-pentenyl)- represents a valuable scaffold in the quest for novel therapeutic agents. Its unique chemical structure, combined with recent advances in synthetic and biological research, positions it as a promising candidate for drug discovery. Continued exploration of its properties and applications is expected to yield significant advancements in the treatment of various diseases, underscoring the importance of this compound in modern pharmaceutical science.

For more information on the latest research and developments related to Benzene, 1-methyl-4-(4-pentenyl)-, readers are encouraged to consult recent publications in the aforementioned journals and other scientific databases. The interdisciplinary nature of this research highlights the collaborative efforts of chemists, pharmacologists, and biologists in advancing the field of drug discovery.

• 768-56-9(4-Phenyl-1-butene)
• 1075-74-7(Benzene, 4-penten-1-yl-)
• 51125-15-6(Benzene, 1-methyl-3-(4-pentenyl)-)
• 53210-25-6(Benzene, 10-undecenyl-)
• 1588-44-9(Benzene, 5-hexen-1-yl-)
• 828-14-8(Benzene, 4-hexenyl-, (E)-)
• 828-13-7(Benzene, 4-hexenyl-, (Z)-)
• 23086-43-3(Benzene, 4-hexen-1-yl-)
• 50703-41-8((5Z)-bicyclo[8.2.2]tetradeca-1(12),5,10,13-tetraene)
• 77446-28-7(1-but-3-enyl-3,5-dimethylbenzene)